25 reports

  • Sleep Aid Value Sales (USD million rsp) 2011/2016 and % CAGR 2011-2016...
  • Western Europe: Sleep Aid Value Sales (USD million rsp) 2016 and % CAGR 2016-2021
  • Sleep Aid
  • World
  • Demand
  • Bayer AG
  • Pfizer Inc.
  • 5.2.2.1 EROSION IN BRANDED PRESCRIPTION SLEEP AID SALES DUE TO GROWING ADOPTION...
  • U.S.: OVER-THE-COUNTER (OTC) SLEEP AIDS MARKET SIZE FOR INSOMNIA, BY TYPE, 2013-2021 (USD MILLION)
  • Sleep Aid
  • United States
  • Company
  • Market Size
  • Merck & Co., Inc.
  • COMPETITIVE LANDSCAPE
  • Summary 2
  • OTC
  • Sleep Aid
  • Canada
  • Demand
  • WN Pharmaceuticals Ltd.
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • Sleep Aid
  • United States
  • Demand
  • Bayer AG
  • Walgreen Co.

The sleeping aid products industry has witnessed huge growth in the recent years.

  • OTC
  • Sleep Aid
  • World
  • Market Size

Adverse effects of sleep aid medication\n##. ##. ##. ##.

  • OTC
  • Sleep Aid
  • World
  • Market Size
  • PROSPECTS

Woo Hwang Chung Sim Won is more intended to reduce anxiety levels, rather than acting as an out-an-out sleep aid.

  • OTC
  • Sleep Aid
  • Vitamin
  • South Korea
  • Demand
  • TRENDS
  • PROSPECTS

The increasing attention being paid to sleep-related problems and rising number of sufferers could be seen as an opportunity for sleep aid manufacturers.

  • OTC
  • Pharmaceutical
  • Sleep Aid
  • Japan
  • Demand
  • COMPETITIVE LANDSCAPE
  • interviews
  • Sleep Aid
  • Canada
  • Bayer AG
  • Jamieson Laboratories Ltd.
  • Valeant Pharmaceuticals International, Inc.
  • PROSPECTS

Abbott Laboratorios, on the other TRENDS Passport ## PROSPECTS hand, does not actively advertise its sleep aid products, but rather focuses on doctor recommendations.

  • OTC
  • Sleep Aid
  • Mexico
  • Demand

On the basis of sleep disorder, the sleep aids market comprises insomnia, sleep apnea, restless legs syndrome, narcolepsy and sleep walking.

  • OTC
  • Sleep Aid
  • World
  • Market Size
  • TRENDS
  • COMPETITIVE LANDSCAPE
  • Sleep Aid
  • United States
  • Demand
  • Bayer AG
  • CVS Caremark Corporation
  • COMPETITIVE LANDSCAPE

Valverde is a herbal sleep aid that is considered mild and safe by consumers, and enjoys high credibility.

  • OTC
  • Sleep Aid
  • Switzerland
  • Demand
  • Vifor Pharma
  • PROSPECTS

However, over the review period Vemedia started to expand its portfolio with Sleepzz, a sleep aid especially targeted towards children.

  • OTC
  • Sleep Aid
  • Netherlands
  • Demand
  • TRENDS

This is regarded by consumers as both a sedative and a sleep aid.

  • OTC
  • Sleep Aid
  • Russian Federation
  • Demand
  • TRENDS

If sleeping problems escalate to the point that they fit the medical definition of a sleep disorder, many consumers either opt to visit a physician or to buy a sleep aid that would help them to get more sleep.

  • Sleep Aid
  • Austria
  • Demand
  • Forecast
  • Kwizda Pharma GmbH
  • summarizes the minor therapeutic classes in the insomnia market.
  • 6.3 OTHER THERAPEUTIC CLASSES

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Pfizer Inc.
  • TRENDS

If sleeping problems escalate to the point that they fit the medical definition of a sleep disorder, many consumers either opt to visit a physician or to buy a sleep aid that would help them to get more sleep.

  • Sleep Aid
  • Vitamin
  • Austria
  • Demand
  • Forecast

Higher stress levels amongst people in developed nations and fast changing life styles in the developing nations are expected to remain key growth drivers for the sleeping aid products during the period of study and are also expected to intensify as population with higher stress le

  • OTC
  • Sleep Aid
  • Market Size
  • 5.3 OTHER THERAPEUTIC CLASSES
  • summarizes the minor therapeutic classes in the insomnia market.

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Europe
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • PROSPECTS

Pharmaco (NZ) Ltd, with its non-herbal/ traditional sleep aid Unisom, ranked fourth in 2016 with a value share of ##%.

  • OTC
  • Sleep Aid
  • New Zealand
  • Demand
  • Vitaco Health NZ Ltd
  • SUMMARY OF MINOR THERAPEUTIC CLASSES, 2015
  • 5.3 OTHER THERAPEUTIC CLASSES

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Takeda Pharmaceutical Company Limited
  • SUMMARY OF MINOR THERAPEUTIC CLASSES, 2015
  • summarizes the minor therapeutic classes in the insomnia market.

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Takeda Pharmaceutical Company Limited
  • 5.1 BIBLIOGRAPHY

FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose.

  • Sleep Aid
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Neurim Pharmaceuticals Ltd
  • Pernix Therapeutics Holdings, Inc.
  • Sports nutrition
  • Seeking improved sleep: More options for consumers
  • Sleep Aid
  • China
  • Europe
  • World
  • Demand